Selected research
Industry Research
Pharma Forecasting Software Industry Research Report 2026
Market perspective
The global Pharma Forecasting Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pharma Forecasting Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharma Forecasting Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharma Forecasting Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharma Forecasting Software include IQVIA, JMP, SAS Institute, Oracle, Inpharmation, J+D Forecasting, ZS Associate, Cognizant and Kinaxis, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pharma Forecasting Software market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharma Forecasting Software.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharma Forecasting Software Market by Company
IQVIA
JMP
SAS Institute
Oracle
Inpharmation
J+D Forecasting
ZS Associate
Cognizant
Kinaxis
Axtria
Symphony Health
Manthan
Model N
Sarjen
Koerber Pharma
WNS
SoftGroup
Nanjing Haiwei Pharmaceutical Technology
Pharma Forecasting Software Segment by Type
Stability Prediction
Formulation and Process Development
Other
Pharma Forecasting Software Segment by Application
Pharmaceutical Companies
Contract Research Organizations (CROs)
Other
Pharma Forecasting Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Forecasting Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharma Forecasting Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Forecasting Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharma Forecasting Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Stability Prediction
- Formulation and Process Development
- Other
Applications
- Pharmaceutical Companies
- Contract Research Organizations (CROs)
- Other
Companies covered
- IQVIA
- JMP
- SAS Institute
- Oracle
- Inpharmation
- J+D Forecasting
- ZS Associate
- Cognizant
- Kinaxis
- Axtria
- Symphony Health
- Manthan
- Model N
- Sarjen
- Koerber Pharma
- WNS
- SoftGroup
- Nanjing Haiwei Pharmaceutical Technology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharma Forecasting Software by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Stability Prediction
- 2.2.3 Formulation and Process Development
- 2.2.4 Other
- 2.3 Pharma Forecasting Software by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Companies
- 2.3.3 Contract Research Organizations (CROs)
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Pharma Forecasting Software Breakdown Data by Type
- 3.1 Global Pharma Forecasting Software Historic Market Size by Type (2021-2026)
- 3.2 Global Pharma Forecasting Software Forecasted Market Size by Type (2027-2032)
4 Pharma Forecasting Software Breakdown Data by Application
- 4.1 Global Pharma Forecasting Software Historic Market Size by Application (2021-2026)
- 4.2 Global Pharma Forecasting Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharma Forecasting Software Market Perspective (2021-2032)
- 5.2 Global Pharma Forecasting Software Growth Trends by Region
- 5.2.1 Global Pharma Forecasting Software Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharma Forecasting Software Historic Market Size by Region (2021-2026)
- 5.2.3 Pharma Forecasting Software Forecasted Market Size by Region (2027-2032)
- 5.3 Pharma Forecasting Software Market Dynamics
- 5.3.1 Pharma Forecasting Software Industry Trends
- 5.3.2 Pharma Forecasting Software Market Drivers
- 5.3.3 Pharma Forecasting Software Market Challenges
- 5.3.4 Pharma Forecasting Software Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharma Forecasting Software Players by Revenue
- 6.1.1 Global Top Pharma Forecasting Software Players by Revenue (2021-2026)
- 6.1.2 Global Pharma Forecasting Software Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharma Forecasting Software Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharma Forecasting Software Head Office and Area Served
- 6.4 Global Pharma Forecasting Software Players, Product Type & Application
- 6.5 Global Pharma Forecasting Software Manufacturers Established Date
- 6.6 Global Pharma Forecasting Software Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharma Forecasting Software Market Size (2021-2032)
- 7.2 North America Pharma Forecasting Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharma Forecasting Software Market Size by Country (2021-2026)
- 7.4 North America Pharma Forecasting Software Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharma Forecasting Software Market Size (2021-2032)
- 8.2 Europe Pharma Forecasting Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharma Forecasting Software Market Size by Country (2021-2026)
- 8.4 Europe Pharma Forecasting Software Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharma Forecasting Software Market Size (2021-2032)
- 9.2 Asia-Pacific Pharma Forecasting Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharma Forecasting Software Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharma Forecasting Software Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharma Forecasting Software Market Size (2021-2032)
- 10.2 South America Pharma Forecasting Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharma Forecasting Software Market Size by Country (2021-2026)
- 10.4 South America Pharma Forecasting Software Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharma Forecasting Software Market Size (2021-2032)
- 11.2 Middle East & Africa Pharma Forecasting Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharma Forecasting Software Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharma Forecasting Software Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 IQVIA
- 12.1.1 IQVIA Company Information
- 12.1.2 IQVIA Business Overview
- 12.1.3 IQVIA Revenue in Pharma Forecasting Software Business (2021-2026)
- 12.1.4 IQVIA Pharma Forecasting Software Product Portfolio
- 12.1.5 IQVIA Recent Developments
- 12.2 JMP
- 12.2.1 JMP Company Information
- 12.2.2 JMP Business Overview
- 12.2.3 JMP Revenue in Pharma Forecasting Software Business (2021-2026)
- 12.2.4 JMP Pharma Forecasting Software Product Portfolio
- 12.2.5 JMP Recent Developments
- 12.3 SAS Institute
- 12.3.1 SAS Institute Company Information
- 12.3.2 SAS Institute Business Overview
- 12.3.3 SAS Institute Revenue in Pharma Forecasting Software Business (2021-2026)
- 12.3.4 SAS Institute Pharma Forecasting Software Product Portfolio
- 12.3.5 SAS Institute Recent Developments
- 12.4 Oracle
- 12.4.1 Oracle Company Information
- 12.4.2 Oracle Business Overview
- 12.4.3 Oracle Revenue in Pharma Forecasting Software Business (2021-2026)
- 12.4.4 Oracle Pharma Forecasting Software Product Portfolio
- 12.4.5 Oracle Recent Developments
- 12.5 Inpharmation
- 12.5.1 Inpharmation Company Information
- 12.5.2 Inpharmation Business Overview
- 12.5.3 Inpharmation Revenue in Pharma Forecasting Software Business (2021-2026)
- 12.5.4 Inpharmation Pharma Forecasting Software Product Portfolio
- 12.5.5 Inpharmation Recent Developments
- 12.6 J+D Forecasting
- 12.6.1 J+D Forecasting Company Information
- 12.6.2 J+D Forecasting Business Overview
- 12.6.3 J+D Forecasting Revenue in Pharma Forecasting Software Business (2021-2026)
- 12.6.4 J+D Forecasting Pharma Forecasting Software Product Portfolio
- 12.6.5 J+D Forecasting Recent Developments
- 12.7 ZS Associate
- 12.7.1 ZS Associate Company Information
- 12.7.2 ZS Associate Business Overview
- 12.7.3 ZS Associate Revenue in Pharma Forecasting Software Business (2021-2026)
- 12.7.4 ZS Associate Pharma Forecasting Software Product Portfolio
- 12.7.5 ZS Associate Recent Developments
- 12.8 Cognizant
- 12.8.1 Cognizant Company Information
- 12.8.2 Cognizant Business Overview
- 12.8.3 Cognizant Revenue in Pharma Forecasting Software Business (2021-2026)
- 12.8.4 Cognizant Pharma Forecasting Software Product Portfolio
- 12.8.5 Cognizant Recent Developments
- 12.9 Kinaxis
- 12.9.1 Kinaxis Company Information
- 12.9.2 Kinaxis Business Overview
- 12.9.3 Kinaxis Revenue in Pharma Forecasting Software Business (2021-2026)
- 12.9.4 Kinaxis Pharma Forecasting Software Product Portfolio
- 12.9.5 Kinaxis Recent Developments
- 12.10 Axtria
- 12.10.1 Axtria Company Information
- 12.10.2 Axtria Business Overview
- 12.10.3 Axtria Revenue in Pharma Forecasting Software Business (2021-2026)
- 12.10.4 Axtria Pharma Forecasting Software Product Portfolio
- 12.10.5 Axtria Recent Developments
- 12.11 Symphony Health
- 12.11.1 Symphony Health Company Information
- 12.11.2 Symphony Health Business Overview
- 12.11.3 Symphony Health Revenue in Pharma Forecasting Software Business (2021-2026)
- 12.11.4 Symphony Health Pharma Forecasting Software Product Portfolio
- 12.11.5 Symphony Health Recent Developments
- 12.12 Manthan
- 12.12.1 Manthan Company Information
- 12.12.2 Manthan Business Overview
- 12.12.3 Manthan Revenue in Pharma Forecasting Software Business (2021-2026)
- 12.12.4 Manthan Pharma Forecasting Software Product Portfolio
- 12.12.5 Manthan Recent Developments
- 12.13 Model N
- 12.13.1 Model N Company Information
- 12.13.2 Model N Business Overview
- 12.13.3 Model N Revenue in Pharma Forecasting Software Business (2021-2026)
- 12.13.4 Model N Pharma Forecasting Software Product Portfolio
- 12.13.5 Model N Recent Developments
- 12.14 Sarjen
- 12.14.1 Sarjen Company Information
- 12.14.2 Sarjen Business Overview
- 12.14.3 Sarjen Revenue in Pharma Forecasting Software Business (2021-2026)
- 12.14.4 Sarjen Pharma Forecasting Software Product Portfolio
- 12.14.5 Sarjen Recent Developments
- 12.15 Koerber Pharma
- 12.15.1 Koerber Pharma Company Information
- 12.15.2 Koerber Pharma Business Overview
- 12.15.3 Koerber Pharma Revenue in Pharma Forecasting Software Business (2021-2026)
- 12.15.4 Koerber Pharma Pharma Forecasting Software Product Portfolio
- 12.15.5 Koerber Pharma Recent Developments
- 12.16 WNS
- 12.16.1 WNS Company Information
- 12.16.2 WNS Business Overview
- 12.16.3 WNS Revenue in Pharma Forecasting Software Business (2021-2026)
- 12.16.4 WNS Pharma Forecasting Software Product Portfolio
- 12.16.5 WNS Recent Developments
- 12.17 SoftGroup
- 12.17.1 SoftGroup Company Information
- 12.17.2 SoftGroup Business Overview
- 12.17.3 SoftGroup Revenue in Pharma Forecasting Software Business (2021-2026)
- 12.17.4 SoftGroup Pharma Forecasting Software Product Portfolio
- 12.17.5 SoftGroup Recent Developments
- 12.18 Nanjing Haiwei Pharmaceutical Technology
- 12.18.1 Nanjing Haiwei Pharmaceutical Technology Company Information
- 12.18.2 Nanjing Haiwei Pharmaceutical Technology Business Overview
- 12.18.3 Nanjing Haiwei Pharmaceutical Technology Revenue in Pharma Forecasting Software Business (2021-2026)
- 12.18.4 Nanjing Haiwei Pharmaceutical Technology Pharma Forecasting Software Product Portfolio
- 12.18.5 Nanjing Haiwei Pharmaceutical Technology Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst